Pharmacists authorization to initiate, prescribe, administer, and dispense certain drugs for the treatment of opioid use disorder
This bill expands the scope of practice for pharmacists in Minnesota by authorizing them to initiate, prescribe, administer, and dispense certain medications specifically for treating opioid use disorder. The legislation directly affects licensed pharmacists and pharmacist interns, allowing them to manage drug therapy for addiction treatment under established protocols or collaborative practice agreements with other healthcare providers. Key provisions include modifying the legal definition of a "practitioner" to include pharmacists authorized for these specific treatments and adjusting disciplinary grounds for pharmacists to reflect their expanded responsibilities. The bill also requires documentation of any therapy changes in patient medical records and maintains oversight through collaboration with dentists, physicians, nurse practitioners, and other licensed healthcare professionals.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 17, 2026
Last action Mar 17, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Mar 17, 2026
Committee
Referred to Health and Human Services
upper
Mar 17, 2026
Introduced
Introduction and first reading
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
John Hoffman
DDemocratic-Farmer-Labor
Ask Maddy
·
AI policy assistant
Ask Maddy about SF 4486
Scope: MN
Hi! I can help you understand SF 4486. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline